AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
OXSQG

Oxford Square Capital Corp. 5.50% Notes due 2028 (OXSQG) fair value

Consumer Discretionary · Other Consumer Services · NASDAQ · United States
$23.85-0.13%
Market cap $248MUpdated Oct 20, 2026
Our verdict
Trades 19% above our fair value
Price
$23.85
Model fair valueConfidence: low
about $20.07
Built from weaker models, sales multiples or analyst targets, so treat it as a rough guide.
Not used by alerts or posts.
Treated as a pre-revenue company. None of the usual models had enough data, so this uses Net asset value, Discounted cash flow, and Dividend discount instead.
ACCE opinionOxford Square Capital Corp. 5.50% Notes due 2028 (OXSQG)
Fair value (2 models)
Not available
ACCE price target
$24.55
Rating
Not rated
Horizon
12 months
ACCE price target published on 15 Oct 2026, 00:00 CEST.
Price used: $23.85 at the close on 23 Oct 2026, 22:00 CEST.
Models: Net asset value, Discounted cash flow, and Dividend discount.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
34
out of 100
P/E
0.0x
forward 0.0x
1-year return
-0.1%
Dividend yield
5.95%

Oxford Square Capital Corp. 5.50% Notes due 2028 in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Oxford Square Capital Corp. (OXSQG) is the 5.50% notes due 2028 issued by a closed-end investment company that lends to lower middle-market companies, so the instrument is a fixed-coupon debt claim on a BDC portfolio rather than an equity stake. The notes are structurally senior to the fund's common equity, which is the main reason to look at them, but that protection depends on the health of a loan book that the reported data does not let us check. The data we have is thin: the score is 39/100, there are no earnings multiples or margins to anchor a view, and the reported 50.6% ROE reflects the fund's leverage and the way BDCs report income rather than operating strength. The name is not in any index, which limits forced buying or selling as a support or a drag. A deeper look would need the portfolio's non-accrual rate, the notes' yield to maturity against the current coupon, and the fund's asset coverage ratio relative to the regulatory minimum.

AI-assisted·How I use AIWritten Oct 18, 2026

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where OXSQG's valuation models land
Price
$23.85
Model fair valueConfidence: low
about $20.07
Model
Fair value
Upside
Net asset value
Discounted cash flow
Dividend discount
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

News and Record

Press releases mentioning this company

Recent performance

1 week
-0.2%
1 month
-2.3%
3 months
-2.5%
6 months
-0.8%
YTD
-1.3%
1 year
-0.1%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
15 Oct 2026, 00:00 CESTACCE price target$24.55first publication$24.55
5 Aug 2026, 00:00 CESTFair value$31.54$32.06$24.14
30 Jun 2026, 00:00 CESTFair value$32.06first publication$24.12

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full OXSQG page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth7Value36Quality51Momentum40Total34
Valuation
Trailing P/E
0.0x
Forward P/E
0.0x
PEG
no data
P/B
0.00x
EV / Revenue
0.0x
Book value/sh
no data
Enterprise value
$0
Profitability
ROE
50.6%
FCF yield
7.38%
ROIC
-5.1%
Health and risk
Debt / equity
1.08
Dividend yield
5.95%
Beta
no data

Price

-1.4% · 1Y

Ask anything about OXSQG

Answered from Oxford Square Capital Corp. 5.50% Notes due 2028 fundamentals + recent valuations. Every number shows its source and date.

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
OXSQG Oxford Square Capital Corp. 5.50% Notes due 2028$23.85---50.6%5134
BBBY Bed Bath & Beyond Inc. Common Stock$1.71---0.0%3726

Sector report card

Where OXSQG ranks against its sector peers on each metric.

Computing percentiles…
  • GlobeNewswire•Jul 31, 2026
    Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended June 30, 2026 and Declaration of Distributions on Common Stock for the Months Ending October 31, November 30, and December 31, 2026
  • GlobeNewswire•Jul 27, 2026
    Oxford Square Capital Corp. Schedules Second Quarter 2026 Earnings Release and Conference Call for July 31, 2026
  • GlobeNewswire•Apr 29, 2026
    Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended March 31, 2026 and Declaration of Distributions on Common Stock for the Months Ending July 31, August 31, and September 30, 2026
2 more press releases · full archive on Investor+.INVESTOR
18 filings of 40
September 2026
Sep 14
8-KCurrent reportPeriod 2026-09-14
View on SEC →
Sep 14
Form 4Insider transactionPeriod 2026-09-03
View on SEC →
August 2026
Aug 20
8-KCurrent reportPeriod 2026-08-20
View on SEC →
15 more filings + AI summaries on Investor+.INVESTOR